Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Orchard Therapeutics (Europe) Limited is currently prosecuting a patent portfolio in the Biotechnology & Pharmaceuticals technology area. The company has 2 pending office actions, which are distributed across 2 distinct art units. This distribution indicates that the company's current legal efforts are split between different technical specialties at the USPTO. Managing these pending office actions in separate art units requires a strategy that can adapt to different examination standards.
The company's applications are being reviewed by 2 distinct examiners. The busiest examiner is PERSONS, JENNA L, who has a busiest examiner pending count of 1. This busiest examiner pending count of 1 shows how the workload is divided among the examiners involved in the company's prosecution. Each examiner is responsible for a portion of the total 2 pending office actions, requiring the company to maintain multiple lines of communication.
With multiple examiners and art units, the portfolio's current activity is not concentrated under a single official. Practitioners must tailor their responses to the specific feedback of PERSONS, JENNA L and the other assigned examiner. The Biotechnology & Pharmaceuticals focus remains the common thread across the pending office actions currently facing the company.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 2 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| PERSONS, JENNA L | 1 | 50.8% | +61.7% |
| NOBLE, MARCIA STEPHENS | 1 | 67.0% | +39.9% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17768300 | COMPOSITIONS AND METHODS FOR MODIFYING EUKARYOTIC CELLS | NOBLE, MARCIA STEPHENS | 30d |
| 17771524 | COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING CROHN'S DISEASE | PERSONS, JENNA L | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17768300 | COMPOSITIONS AND METHODS FOR MODIFYING EUKARYOTIC CELLS | NOBLE, MARCIA STEPHENS | 30d |
| 17771524 | COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING CROHN'S DISEASE | PERSONS, JENNA L | — |
| Art Unit | Apps |
|---|---|
| 1637 | 1 |
| 1632 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 17771524 | COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING CROHN'S DISEASE | PERSONS, JENNA L | 1637 | §103§112 | Final Rejection | — | Pending | Apr 25, 2022 |
| 17768300 | COMPOSITIONS AND METHODS FOR MODIFYING EUKARYOTIC CELLS | NOBLE, MARCIA STEPHENS | 1632 | §102§112 | Non-Final OA | 30d | Pending | Apr 12, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial